Jonathan A. Kropski

15.5k total citations · 3 hit papers
67 papers, 3.4k citations indexed

About

Jonathan A. Kropski is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Molecular Biology. According to data from OpenAlex, Jonathan A. Kropski has authored 67 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Pulmonary and Respiratory Medicine, 13 papers in Epidemiology and 12 papers in Molecular Biology. Recurrent topics in Jonathan A. Kropski's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (33 papers), Neonatal Respiratory Health Research (18 papers) and Medical Imaging and Pathology Studies (17 papers). Jonathan A. Kropski is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (33 papers), Neonatal Respiratory Health Research (18 papers) and Medical Imaging and Pathology Studies (17 papers). Jonathan A. Kropski collaborates with scholars based in United States, Australia and United Kingdom. Jonathan A. Kropski's co-authors include Timothy S. Blackwell, Gordon L. Jensen, James E. Loyd, J.C. Hewlett, William E. Lawson, Lorraine B. Ware, Richard D. Fremont, Joyce Lee, Nicholas E. Banovich and Lisa R. Young and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Jonathan A. Kropski

64 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Idiopathic pulmonary fibrosis: Disease mechanisms and drug development

2020 392 citations Jonathan A. Kropski, Joyce Lee et al. profile →
Persistence of a regeneration-associated, transitional alveolar epithelial cell state in pulmonary fibrosis

2020 319 citations Nicholas E. Banovich, Jonathan A. Kropski et al. profile →
Idiopathic pulmonary fibrosis: Epithelial-mesenchymal interactions and emerging therapeutic targets

2018 240 citations J.C. Hewlett, Jonathan A. Kropski et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jonathan A. Kropski United States	30	2.3k	732	457	401	345	67	3.4k
S. Marchand‐Adam France	34	2.2k 0.9×	629 0.9×	773 1.7×	394 1.0×	176 0.5×	132	3.6k
Richard M. Logan Australia	38	3.1k 1.3×	1.1k 1.5×	430 0.9×	470 1.2×	159 0.5×	93	5.0k
J. Michael Wells United States	29	2.0k 0.9×	623 0.9×	702 1.5×	196 0.5×	77 0.2×	100	3.2k
David H. Ingbar United States	32	1.3k 0.5×	1.3k 1.8×	216 0.5×	413 1.0×	150 0.4×	92	3.3k
Ewa Jassem Poland	27	880 0.4×	766 1.0×	561 1.2×	160 0.4×	144 0.4×	209	2.6k
Yingze Zhang United States	30	2.2k 1.0×	1.2k 1.7×	802 1.8×	291 0.7×	304 0.9×	139	4.2k
Adam Clauss Sweden	10	1.6k 0.7×	340 0.5×	314 0.7×	535 1.3×	177 0.5×	13	3.4k
María Molina‐Molina Spain	33	2.8k 1.2×	407 0.6×	881 1.9×	238 0.6×	267 0.8×	187	3.6k
Gerard M. Turino United States	38	2.6k 1.1×	656 0.9×	656 1.4×	530 1.3×	195 0.6×	140	4.6k
Georg Schatzl Austria	38	1.5k 0.7×	841 1.1×	138 0.3×	666 1.7×	185 0.5×	97	4.2k

Countries citing papers authored by Jonathan A. Kropski

Since Specialization

Citations

This map shows the geographic impact of Jonathan A. Kropski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan A. Kropski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan A. Kropski more than expected).

Fields of papers citing papers by Jonathan A. Kropski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan A. Kropski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan A. Kropski. The network helps show where Jonathan A. Kropski may publish in the future.

Co-authorship network of co-authors of Jonathan A. Kropski

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan A. Kropski. A scholar is included among the top collaborators of Jonathan A. Kropski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan A. Kropski. Jonathan A. Kropski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Negretti, Nicholas M., Christopher S. Jetter, Meghan Kapp, et al.. (2025). Bronchopulmonary dysplasia with pulmonary hypertension associates with semaphorin signaling loss and functionally decreased FOXF1 expression. Nature Communications. 16(1). 5004–5004. 1 indexed citations

Salisbury, Margaret L., Cheryl Markin, Adam Guttentag, et al.. (2024). Progressive Early Interstitial Lung Abnormalities in Persons at Risk for Familial Pulmonary Fibrosis: A Prospective Cohort Study. American Journal of Respiratory and Critical Care Medicine. 210(12). 1441–1452. 3 indexed citations

Natri, Heini M., Christina B. Azodi, Lance Peter, et al.. (2024). Cell-type-specific and disease-associated expression quantitative trait loci in the human lung. Nature Genetics. 56(4). 595–604. 16 indexed citations

Hu, Yang, André F. Rendeiro, Hiranmayi Ravichandran, et al.. (2023). A Unique Cellular Organization of Human Distal Airways and Its Disarray in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 207(9). 1171–1182. 32 indexed citations

Kim, John S., Sydney B. Montesi, Ayodeji Adegunsoye, et al.. (2023). Approach to Clinical Trials for the Prevention of Pulmonary Fibrosis. Annals of the American Thoracic Society. 20(12). 1683–1693. 1 indexed citations

Rosenberg, Adam J., et al.. (2023). Fully automated radiosynthesis of [68Ga]Ga-FAPI-46 with cyclotron produced gallium. EJNMMI Radiopharmacy and Chemistry. 8(1). 29–29. 2 indexed citations

Sucre, Jennifer M. S., Fabian Bock, Nicholas M. Negretti, et al.. (2023). Alveolar repair following LPS-induced injury requires cell-ECM interactions. JCI Insight. 8(14). 12 indexed citations

Han, Wei, Taylor P. Sherrill, Chase J. Taylor, et al.. (2023). Epithelial Yap/Taz are required for functional alveolar regeneration following acute lung injury. JCI Insight. 8(19). 27 indexed citations

Blackwell, Timothy S., J.C. Hewlett, Wendi R. Mason, et al.. (2021). A Phase I Randomized, Controlled, Clinical Trial of Valganciclovir in Idiopathic Pulmonary Fibrosis. Annals of the American Thoracic Society. 18(8). 1291–1297. 8 indexed citations

10.

Furusawa, Haruhiko, Jonathan Cardwell, Tsukasa Okamoto, et al.. (2020). Chronic Hypersensitivity Pneumonitis, an Interstitial Lung Disease with Distinct Molecular Signatures. American Journal of Respiratory and Critical Care Medicine. 202(10). 1430–1444. 75 indexed citations

11.

Salisbury, Margaret L., J.C. Hewlett, Guixiao Ding, et al.. (2020). Development and Progression of Radiologic Abnormalities in Individuals at Risk for Familial Interstitial Lung Disease. American Journal of Respiratory and Critical Care Medicine. 201(10). 1230–1239. 50 indexed citations

12.

Wu, Ann Chen, James P. Kiley, Patricia J. Noel, et al.. (2018). Current Status and Future Opportunities in Lung Precision Medicine Research with a Focus on Biomarkers. An American Thoracic Society/National Heart, Lung, and Blood Institute Research Statement. American Journal of Respiratory and Critical Care Medicine. 198(12). e116–e136. 38 indexed citations

13.

Sucre, Jennifer M. S., Christopher S. Jetter, Holli A. Loomans‐Kropp, et al.. (2018). Successful Establishment of Primary Type II Alveolar Epithelium with 3D Organotypic Coculture. American Journal of Respiratory Cell and Molecular Biology. 59(2). 158–166. 39 indexed citations

14.

Sucre, Jennifer M. S., Gail Deutsch, Christopher S. Jetter, et al.. (2018). A Shared Pattern of β-Catenin Activation in Bronchopulmonary Dysplasia and Idiopathic Pulmonary Fibrosis. American Journal Of Pathology. 188(4). 853–862. 30 indexed citations

15.

Kropski, Jonathan A., Sara Reiss, Cheryl Markin, et al.. (2017). Rare Genetic Variants in PARN Are Associated with Pulmonary Fibrosis in Families. American Journal of Respiratory and Critical Care Medicine. 196(11). 1481–1484. 24 indexed citations

16.

Gaskill, Christa, Erica J. Carrier, Jonathan A. Kropski, et al.. (2017). Disruption of lineage specification in adult pulmonary mesenchymal progenitor cells promotes microvascular dysfunction. Journal of Clinical Investigation. 127(6). 2262–2276. 34 indexed citations

17.

Hemnes, Anna R., Min Zhao, James West, et al.. (2016). Critical Genomic Networks and Vasoreactive Variants in Idiopathic Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 194(4). 464–475. 55 indexed citations

18.

Mont, Stacey, Sean S. Davies, L. Jackson Roberts, et al.. (2016). Accumulation of isolevuglandin-modified protein in normal and fibrotic lung. Scientific Reports. 6(1). 24919–24919. 25 indexed citations

19.

Gaskill, Christa, Swapna Menon, Lora K. Hedges, et al.. (2016). Shared Gene Expression Patterns in Mesenchymal Progenitors Derived from Lung and Epidermis in Pulmonary Arterial Hypertension: Identifying Key Pathways in Pulmonary Vascular Disease. Pulmonary Circulation. 6(4). 483–497. 19 indexed citations

20.

Kropski, Jonathan A., Richard D. Fremont, Carolyn S. Calfee, & Lorraine B. Ware. (2009). Clara Cell Protein (CC16), a Marker of Lung Epithelial Injury, Is Decreased in Plasma and Pulmonary Edema Fluid From Patients With Acute Lung Injury. CHEST Journal. 135(6). 1440–1447. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact